Investigation on Suicide Risk Factors of Patients With Mood Disorders
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Mood Disorders, Suicide. Basic parameters: 16 years — 60 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Investigation on Suicide Risk Factors of Patients With Mood Disorders in China
Overview
This study investigates the level and distribution of suicide risk and learned suicide ability of patients with mood disorders, investigates the related risk factors of suicide and suicide ability formation of patients with mood disorders from multiple dimensions (biological, psychological, social and clinical perspectives) and clarifies their importance, forms a list of suicide risk factors, and establishes a prediction model of learned suicide ability formation. Upon enrollment, participants will undergo comprehensive assessments including blood and urine sample collection and scale evaluation. The collection of scientific blood and urine is mainly used for the exploration of molecular mechanism of disease occurrence and development, the discovery and verification of biomarkers. Scale evaluation includes: Beck Scale for Suicide Ideation , Columbia Suicide Severity Rating Scale,, Hamilton Depression Rating Scale , Hamilton Anxiety Rating Scale, PHQ-9, GAD-7, Personal and Social Function Scale , Schihan Disability Scale , Emotional Adjustment Difficulty Scale , Acquired Capability for Suicide Scale, Interpersonal Needs Questionnaire , Ottawa Self-Injury Scale, Chinese version of Stress Perception Scale and Beck Hopelessness Scale . Follow-up was carried out for 3 months, including whether suicide/self-injury occurred, current status, and some baseline questionnaires (such as BSI-CV, GAD-7, PHQ-9, HAMD-17,HAMA, etc.).
Primary outcome measures
- Columbia Suicide Severity Rating Scale [Time frame: baseline, 3 months]
Secondary outcome measures (8)
- Beck Scale for Suicide Ideation [Time frame: baseline, 3 months]
- Hamilton Depression Rating Scale [Time frame: baseline, 3 months]
- Hamilton Anxiety Rating Scale [Time frame: baseline, 3 months]
- Patient Health Questionnare [Time frame: baseline, 3 months]
- Generalized Anxiety Disorder [Time frame: baseline, 3 months]
- acquired capability for suicide scale [Time frame: baseline, 3 months]
- Interpersonal Needs Questionnaire [Time frame: baseline, 3 months]
- Beck Hopelessness Scale [Time frame: baseline, 3 months]
Eligibility criteria
Inclusion criteria
- Age: 16 to 60 years old;
- seeing a doctor in a psychiatric clinic or a general hospital;
- Willing to cooperate in this research project;
- Sign the informed consent form (minors also need to obtain the informed consent signature of the guardian);
- Meet the diagnostic criteria of ICD-11 mood disorder.
Exclusion criteria
- unable to understand the contents of the questionnaire;
- Serious organic diseases such as cardiovascular disease, brain disease, liver disease and kidney disease, and weak body, which affect the respondents of the questionnaire;
- Other circumstances that make it impossible or unwilling to cooperate with the completion of the questionnaire.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Tianjin Anding Hospital — Tianjin
Identifiers
NCT: NCT07523490 · MD-SU